Patients without prolonged QRS after TAVI with corevalve device do not experience high-degree atrio-ventricular block

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 5, 2013, Pages 882-887

  Mouillet, Gauthier ^a   Lellouche, Nicolas ^a   Lim, Pascal ^a   Meguro, Kentaro ^a   Yamamoto, Masanori ^a   Deux, Jean François ^a   Monin, Jean Luc ^a   Bergoënd, Eric ^a   Dubois Randé, Jean Luc ^a   Teiger, Emmanuel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Atrio ventricular block; Pacemaker implantation; Transcatheter aortic valve implantation

Indexed keywords

AGED; AORTA VALVE STENOSIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART PACING; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; QRS COMPLEX; RISK ASSESSMENT; SECOND DEGREE ATRIOVENTRICULAR BLOCK; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME; ATRIOVENTRICULAR BLOCK; BIOPROSTHESIS; CHI SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY; EQUIPMENT; HEART CATHETERIZATION; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ATRIOVENTRICULAR BLOCK; BIOPROSTHESIS; CARDIAC CATHETERIZATION; CARDIAC PACING, ARTIFICIAL; CHI-SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84881477884     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24657     Document Type: Article

References (15)

1. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
2. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607.
3. Smith CR, Leon MB, Mack MJ, et al. PARTNER trial investigators: Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-2198.
4. Latsios G, Gerckens U, Grube E. Transaortic transcatheter aortic valve implantation: A novel approach for the truly ''no-access option" patients. Catheter Cardiovasc Interv 2010;75:1129-1136.
5. Piazza N, Nuis RJ, Tzikas A, et al. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 2010;6:475-484.
6. Baan J Jr, Yong ZY, Koch KT, et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 2010;159:497-503.
7. Calvi V, Puzzangara E, Pruiti GP, et al. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol 2009;32 (Suppl 1):S126-S130.
8. Bleiziffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010;3:524-530.
9. Erkapic D, Kim WK, Weber M, et al. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace 2010;12:1188- 1190.
10. Jilaihawi H, Chin D, Vasa-Nicotera M, et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 2009;157:860-866.
11. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006;114:1616-1624.
12. Khawaja MZ, Rajani R, Cook A, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: Incidence and contributing factors (the UK CoreValve Collaborative). Circulation 2011;123:951-960.
13. Fraccaro C, Buja G, Tarantini G, et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 2011;107: 747-754.
14. Munoz-García AJ, Hernández-García JM, Jiménez-Navarro MF, et al. Changes in atrioventricular conduction and predictors of pacemaker need after percutaneous implantation of the CoreValve (R). Aortic valve prosthesis. Rev Esp Cardiol 2010;63:1444- 1451.
15. Haworth P, Behan M, Khawaja M, et al. Predictors for permanent pacing after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010;76:751-756.